| Name | Title | Contact Details |
|---|
At VoxelCloud, our vision is to transform how medical practitioners work with and interpret medical images and clinical data using cloud computing and artificial intelligence, and to improve the lives of millions through accurate, accessible, and timely medical analytics.
At ReSound, people with hearing loss are at the heart of everything we do. We think big and challenge the norm, because we believe Smart Hearing has the power to transform lives. Our award-winning Smart Hearing aids help people feel more involved, connected and in control. They deliver the best sound quality and optimal design. Smart Hearing aids also work like wireless stereo headphones, streaming sound directly to the hearing aids from devices like an iPhone® or a TV. An accompanying app gives full control and the ability to personalize each hearing experience. ReSound hearing aids are exclusively available through hearing care professionals, who adjust them to each individual`s specific hearing loss. With research teams in USA and Holland, we are headquartered in Denmark. ReSound is part of the GN Group, pioneering great sound from world leading ReSound hearing aids to Jabra office headsets and sports headphones. Founded in 1869, building on a strong legacy of innovative audio and communications solutuions, and listed on NSDAQ OMX Copenhagen, GN makes life sound better.
UroMed is a Suwanee, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Barnett & Ramel Optical is a Omaha, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
InfraScan, Inc. is a medical device company that focuses on developing, commercializing, and distributing hand-held diagnostic devices for head injury and stroke assessment based on near infrared (NIR) technology. The Infrascanner enables clinicians to detect effectively, conveniently, and accurately intracranial bleeding in patients with head trauma. Intracranial hematomas are an important treatable cause of secondary brain injury in patients with head trauma. Recent statistics from Iraq shows that 30% of all wounded in action have head injuries; of them 40% have brain hematomas. Dr. Britton Chance (University of Pennsylvania) and Dr. Claudia Robertson (Baylor College of Medicine) invented a NIR system for detection of brain Hematomas and tested it successfully in 305 patients in Baylor. An entrepreneurial team formed a company around this technology in Collaboration with Drexel University and won the Wharton Business Plan competition in April 2004 and the second prize at the global business plan competition in Singapore in October 2004. Office of Naval Research funded the company in May 2004. The company also attracted $1.5M in funding from BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania, from Ben Franklin Technology Partners of Southeastern Pennsylvania, and from Philadelphia Industrial Development Corporation. A multicenter clinical study to support an FDA submission started in July 2006, and on February 2008 an application was submitted to the FDA. After 4 years of review, the FDA cleared Infrascanner Model 1000 as a DeNovo medical technology in December 2011. In January 2013 the FDA cleared the 510(k) of Infrascanner Model 2000.